Atlas FDA

DEFLUX INJECTABLE GEL

FDA premarket approval P000029/S075 · decided 2013-10-17

Approval details

PMA number
P000029
Supplement
S075
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
DEFLUX INJECTABLE GEL
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2013-07-19
Decision date
2013-10-17
Days to decision
90 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
APPROVAL FOR LABELING CHANGES, WHICH ADD TWO ADDITIONAL TECHNIQUES FOR INJECTION, THE HIT AND DOUBLE-HIT.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26